Quantitative PCR to Discriminate Between Pneumocystis Pneumonia and Colonization in HIV and Non-HIV Immunocompromised

Patsharaporn T Sarasombath1, Jerapas Thongpiya1, Monrat Chulanetra1

  • 1Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Frontiers in Microbiology
|November 8, 2021
PubMed

Insights

Quantitative PCR (qPCR) can differentiate Pneumocystis pneumonia (PCP) from colonization in immunocompromised patients. This study established specific DNA copy/μl cut-off values for accurate PCP diagnosis in HIV and non-HIV individuals.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Diagnostic Imaging

Background:

  • Pneumocystis pneumonia (PCP) is a significant opportunistic infection in immunocompromised individuals.
  • Definitive PCP diagnosis requires organism identification in respiratory specimens, but differentiating infection from colonization using qPCR remains challenging.

Purpose of the Study:

  • To evaluate the utility of quantitative PCR (qPCR) in differentiating Pneumocystis pneumonia (PCP) from Pneumocystis jirovecii colonization.
  • To establish diagnostic cut-off values for fungal burden in bronchoalveolar lavage (BAL) specimens.

Main Methods:

  • Retrospective analysis of data from HIV and non-HIV patients diagnosed between 2013-2019.
  • Diagnosis of PCP was based on clinical criteria, radiology, and standard staining methods, blinded to qPCR results.
  • Receiver Operating Characteristic (ROC) curve analysis was used to determine optimal qPCR cut-off values for PCP diagnosis.

Main Results:

  • In non-HIV patients, lower (1,480 DNA copies/μl) and upper (9,655 DNA copies/μl) cut-offs showed high sensitivity (100%) and specificity (72.9% and 95.8%, respectively).
  • In HIV patients, lower (1,480 DNA copies/μl) and upper (12,718 DNA copies/μl) cut-offs demonstrated high sensitivity (100% and 97.9%) and specificity (91.7% and 100%, respectively).
  • Specific cut-off values provided high positive and negative predictive values for PCP diagnosis in both patient groups.

Conclusions:

  • qPCR, with established cut-off values, can effectively differentiate Pneumocystis pneumonia from colonization in both HIV-positive and HIV-negative immunocompromised patients.
  • The established qPCR thresholds offer valuable tools for improving the accuracy and speed of PCP diagnosis.